Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumour. Due to a high tumour recurrence rate, the post-operative overall survival (OS) and disease-free survival (DFS) of ACCs is limited. | Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients